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Introduction: Standard treatment for renal cell carcinoma
(RCC) with renal (T3a) or caval (T3b-c) vein thrombosis
is Radical nephrectomy (RN) plus thrombectomy. Partial
nephrectomy (PN) plus thrombectomy may be used in these
cases, however little evidence exists about this procedure.
Materials and Methods: From 2,552 patients with RCC
T3a-c of a multicentre series, 22 had an imperative PN plus
thrombectomy and were compared, through an individual
matched analysis, with 22 controls who underwent RN plus
thrombus excision. Primary outcomes were long term renal
function, evaluated through serum creatinine levels (sCr),
and cancer specific survival (CSS). Kaplan-Meier curves
were plotted and log-rank test were used for group
comparisons. Results: The 2 groups had no differences in
median age (PN 59, IQ range (IQR) 48-66 years; RN 61,
IQR 59-67 years; p=0.3), mean pre-operative sCr (PN
1.24±0.57 mg/dL; RN 1.17±0.35 mg/dL; p=0.76), mean
maximum tumour diameter (PN 4.86±2.1 cm; RN 5.03±1.9
cm; p=0.79), mean BMI (PN 27.9±7.68 and RN 28.59±4.7
Kg/m2; p=0.37), mean blood loss (PN 1670±2535 mL; RN
2162±3257 mL; p=0.74), median Fuhrman grade (3 in both
groups) and metastasis (4 PN and 3 RN patients; p=1).
Para-aortic lymphadenectomy was performed in 6 cases per
group (p=1) and postoperative complications were
experienced by 10 PN and 14 RN patients (p=0.36). Mean
follow up was 45±47 months (p=0.78), in this time 9 PN
and 13 RN patients died because of disease progression
with a CSS of 59.09% and 40.91% respectively (Figure 1,
p=0.428). At last follow up sCr levels were 1.53±0.63 in
PN group and 1.99±2.27 mg/dl in RN group (p=0.62). At
univariate analysis deceased patients, compared to alive
patients at last follow up, had an increased surgical blood
loss (2794.12±3633 vs. 750±630 mL; p=0.018), an
increased operation time (343.86±148 vs. 218.47±97 min;
p<0.01) and longer hospital stay (14.43±7.5 vs. 8.19±5.18;
p=0.0049). Discussion and Conclusion: In patients with
high-risk RCC plus renal or caval thrombi PN, compared
to RN, may have a non-inferior CSS; maintaining
comparable long-term sCr levels and postoperative
complication rates. Further studies are needed to evaluate
the potential role of PN in T3a-c RCC.
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Figure 1. Kaplan-Meier curves for CSS in partial and radical
groups.
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Introduction: Communication between doctors is traditionally
conducted by written clinical charts. Mobile health is
becoming an integral part of modern medical systems,
improving accessibility and quality of medical care. Recent
papers suggest that an increasing number of doctors are using
in their clinical practice mobile tools to communicate clinical
informations (1, 2). The aim of our study was to verify the
adoption of WhatsApp Messenger in everyday clinical
practice to obtain a real-time multidisciplinary collaboration
among medical centers located in different areas of the city.
Materials and Methods: In January 2016 a WhatsApp
Messenger group was created among 25 specialists: 9
urologists, 9 oncologists, 3 urology residents, 3
radiotherapists and 1 general practitioner. A general
coordinator and a group coordinator for each specialty was
monthly appointed. The participants were invited to interact
within the group clinical cases of genitourinary tumors of
particular complexity requiring a multidisciplinary approach.
All the chats were registered. A preliminary analysis of the
activity of the group was planned after the first 10 entered
patients. An evaluation questionnaire was sent after 6 months
to evaluate the level of appreciation. The questionnaire was
composed of a first section investigating the appreciation
among the members of the group and a second section
analyzing the impact in their everyday clinical practice of
whatsapp multidisciplinary consultation. Results: In 10 (91%)
out of 11 patients the WhatsApp consultation was completed,
one case was not of oncological interest. An average of 8
(range=2-13) specialists joined the chat for each patient. An
average of 17.6 (range: 4-43) interventions for each clinical
case was recorded. On the average, 27%, 54% and 19% of
the interventions for each clinical case were provided by
oncologists, urologists and radiotherapists respectively. In 9
(81.8%) cases a final agreement on the patient's management
was reached. At the evaluation questionnaire in a scale 1-10,
the average rating score of appreciation was 7.8 (range=4-10).
Relevant suggestions to improve the Whatsapp Messenger
consultation were obtained and will be considered for future
application the ameliorate the tool. Discussion: WhatsApp is
a useful alternative and powerful complementary
communication tool because of its capability to rapidly
transfer large amount of clinical and radiological data. In our
experience this new approach for multidisciplinary
consultations improved collaboration among different
specialist in different areas of the city through an easier and
more informal change of opinions. In difficult and complex
cases a rapid multidisciplinary approach allowed to offer the
patient a personalized and tailored therapy management.
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Introduction: The aim of the present study was to assess dose
factors affecting the incidence of patient-reported urinary
toxicity at three years after radical radiotherapy (RT) for
prostate cancer in a large group of patients enrolled in a
prospective, multi-centric trial in the period 2010-2014.
Patients and Methods: Enrolled patients were treated in seven
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